Jacques-Eric GOTTENBERG
University Hospital, Strasbourg, France · niversity Hospital, Strabourg - France · Hôpitaux Universitaires de Strasbourg
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jacques-Eric GOTTENBERG as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:37 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05092984 · Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)University Hospital, Strasbourg, France · recruiting · Rheumatoid Arthritis · principal investigator
- Ph4NCT03849131 · Patient-Reported AutoImmunity Secondary to Cancer immunothErapyUniversity Hospital, Strasbourg, France · active not recruiting · Opportunistic Autoimmune Diseases · principal investigator
- N/ANCT02350491 · Study During Pregnancy of Expression of miRNAs in RA or SLEUniversity Hospital, Strasbourg, France · completed · Rheumatoid Arthritis, Systemic Lupus Erythematosus · study director
- Ph2/Ph3NCT01782235 · Efficacy of Tocilizumab in Primary Sjögren's Syndrome.University Hospital, Strasbourg, France · completed · Primary Sjögren's Syndrome (pSS) · principal investigator
- Ph4NCT01000441 · Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid ArthritisUniversity Hospital, Strasbourg, France · completed · Rheumatoid Arthritis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:37 UTC. The ranking covers the 200 most relevant of 28 PubMed records, and a shared surname and initials can bring in a namesake. All 28 on PubMed
- Treatment of primary Sjögren syndrome with rituximab: a randomized trial.Ann Intern Med · 2014321 citationsRCR 11.4
- 268 citationsRCR 12.2
- 242 citationsRCR 9.3
- Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial.Ann Rheum Dis · 2021108 citationsRCR 7.6
- Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome.Blood · 2013103 citationsRCR 2.7
- 98 citationsRCR 8.2
- Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial.Ann Rheum Dis · 202191 citationsRCR 6.9
- Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.Arthritis Care Res (Hoboken) · 201772 citationsRCR 4.0
- Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren's syndrome: a randomized, phase 2, double-blind, placebo-controlled study.Rheumatology (Oxford) · 202265 citationsRCR 5.3
- Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren's syndrome in the JOQUER randomized trial.Rheumatology (Oxford) · 202055 citationsRCR 2.8